Join the discussion — anonymously
Sign in to comment, reply, and vote. Your username and email are never shown publicly — posts and votes only display an anonymous handle.
Comments (2)
I've noticed the same thing. It's definitely not just you. Seems like a company-wide trend for sure. Makes it tough to plan ahead and execute efficiently when you're constantly fighting for every resource. I hope leadership communicates the reasoning soon, because the uncertainty is starting to impact morale and productivity across the board.
Could this be tied to upcoming R&D investments or maybe a shift in focus for certain therapeutic areas? Sometimes budget constraints signal a strategic pivot that hasn't been formally announced yet. It's frustrating, but if it means we're prioritizing areas with higher potential, it might be a necessary evil in the long run. Still, transparency would go a long way.